EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Serum Retinol and Carotenoids in Association with Biomarkers of Insulin Resistance among Premenopausal Women

Stacy A. Blondin, Edwina H. Yeung, Sunni L. Mumford, Cuilin Zhang, Richard W. Browne, Jean Wactawski-Wende, Enrique F. Schisterman

ISRN Nutrition · 2013

DOI: 10.5402/2013/619516 ↗
AbstractBibliografische Angaben

Abstract

Objective . The aim of this study was to investigate how serum retinol and carotenoids ( β -carotene, β -cryptoxanthin, lutein/zeaxanthin, lycopene) are associated with biomarkers of insulin resistance. Research Methods and Procedures . The BioCycle Study (2005–2007) is a prospective cohort of 259 healthy premenopausal women. Fasting serum samples were collected at up to sixteen clinic visits, from which retinol, carotenoids, insulin, glucose, and sex hormone-binding globulin (SHBG) were measured. Insulin resistance was estimated by the homeostasis model assessment (HOMA-IR). Linear mixed models were used to determine associations adjusting for age, race, body mass index (BMI), education, smoking, physical activity, triglycerides, and energy intake. Results . Retinol was positively associated with HOMA-IR ( β = 0.19 (95% CI: 0.07, 0.32)) units per ug/mL increase in retinol; the relationship was driven by insulin ( β = 0.20 (95% CI: 0.08, 0.31)). Retinol was inversely associated with SHBG ( β = −0.22 (95% CI: −0.28, −0.16)). Although no significant associations were found between serum carotenoids and HOMA-IR, β -carotene was positively associated with SHBG and β -cryptoxanthin inversely with fasting plasma glucose. Conclusion . Results indicate a possible role for serum retinol in the pathogenesis of type 2 diabetes. However, they do not support a strong association between individual or total serum carotenoids and insulin resistance.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →